Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission

Chang, XL; Webb, GM; Wu, HL; Greene, JM; Abdulhaqq, S; Bateman, KB; Reed, JS; Pessoa, C; Weber, WC; Maier, N; Chew, GM; Gilbride, RM; Gao, LN; Agnor, R; Giobbi, T; Torgerson, J; Siess, D; Burnett, N; Fischer, M; Shiel, O; Moats, C; Patterson, B; Dhody, K; Kelly, S; Pourhassan, N; Magnani, DM; Smedley, J; Bimber, BN; Haigwood, NL; Hansen, SG; Brown, TR; Ndhlovu, LC; Sacha, JB

Sacha, JB (corresponding author), Vaccine & Gene Therapy Inst, Portland, OR 97239 USA.; Sacha, JB (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA.; Ndhlovu, LC (corresponding author), Weill Cornell Med, Div Infect Dis, Dept Med, New York, NY 10065 USA.

NATURE COMMUNICATIONS, 2021; 12 (1):

Abstract

In the absence of a prophylactic vaccine, the use of antiretroviral therapy (ART) as pre-exposure prophylaxis (PrEP) to prevent HIV acquisition by uni......

Full Text Link